Our results indicate a clear positive correlation between elevated AIP levels and the risk of developing cognitive impairment, suggesting that the AIP may serve as a practical and reliable lipid-based biomarker for predicting cognitive decline. This evidence concerns the gene AIP and Cognitive impairment.